HMGCR and breast neoplasm: Based on the TCGA database, the gene expression levels of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR), a rate-limiting enzyme involved in the cholesterol biosynthesis pathway, are significantly higher in luminal breast tumours compared to triple-negative (TN) breast tumours (Figure 1H).